These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9337997)

  • 1. Proteolytic fragments of insulin-like growth factor binding protein-3: N-terminal sequences and relationships between structure and biological activity.
    Lalou C; Sawamura S; Segovia B; Ogawa Y; Binoux M
    C R Acad Sci III; 1997 Aug; 320(8):621-8. PubMed ID: 9337997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate carcinoma (PC-3) cell proliferation is stimulated by the 22-25-kDa proteolytic fragment (1-160) and inhibited by the 16-kDa fragment (1-95) of recombinant human insulin-like growth factor binding protein-3.
    Angelloz-Nicoud P; Lalou C; Binoux M
    Growth Horm IGF Res; 1998 Feb; 8(1):71-5. PubMed ID: 10990447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin.
    Lalou C; Lassarre C; Binoux M
    Endocrinology; 1996 Aug; 137(8):3206-12. PubMed ID: 8754741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis.
    Fowlkes JL; Serra DM; Rosenberg CK; Thrailkill KM
    J Biol Chem; 1995 Nov; 270(46):27481-8. PubMed ID: 7499205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGF is a cell growth inhibitor.
    Lalou C; Lassarre C; Binoux M
    Prog Growth Factor Res; 1995; 6(2-4):311-6. PubMed ID: 8817674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation.
    Fowlkes JL; Thrailkill KM; George-Nascimento C; Rosenberg CK; Serra DM
    Endocrinology; 1997 Jun; 138(6):2280-5. PubMed ID: 9165012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of proteolytic fragments of insulin-like growth factor-binding protein-3.
    Lalou C; Lassarre C; Binoux M
    Horm Res; 1996; 45(3-5):156-9. PubMed ID: 8964575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases.
    Angelloz-Nicoud P; Harel L; Binoux M
    Growth Regul; 1996 Sep; 6(3):130-6. PubMed ID: 8894645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of circulating fragments of the insulin-like growth factor binding protein-3.
    Kübler B; Draeger C; John H; Andag U; Scharf JG; Forssmann WG; Braulke T; Ständker L
    FEBS Lett; 2002 May; 518(1-3):124-8. PubMed ID: 11997031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the role of human insulin-like growth factor-II (IGF-II)-dependent IGF binding protein (hIGFBP)-4 protease in human osteoblasts using protease-resistant IGFBP-4 analogs.
    Qin X; Byun D; Strong DD; Baylink DJ; Mohan S
    J Bone Miner Res; 1999 Dec; 14(12):2079-88. PubMed ID: 10620067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine.
    Vorwerk P; Yamanaka Y; Spagnoli A; Oh Y; Rosenfeld RG
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1392-5. PubMed ID: 9543173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragments.
    Booth BA; Boes M; Bar RS
    Am J Physiol; 1996 Sep; 271(3 Pt 1):E465-70. PubMed ID: 8843739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D.
    Claussen M; Kübler B; Wendland M; Neifer K; Schmidt B; Zapf J; Braulke T
    Endocrinology; 1997 Sep; 138(9):3797-803. PubMed ID: 9275067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.
    Devi GR; Yang DH; Rosenfeld RG; Oh Y
    Endocrinology; 2000 Nov; 141(11):4171-9. PubMed ID: 11089550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of intact insulin-like growth factor-binding protein-3 in human plasma using a ligand immunofunctional assay.
    Lassarre C; Binoux M
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1260-6. PubMed ID: 11238518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.
    Mark S; Kübler B; Höning S; Oesterreicher S; John H; Braulke T; Forssmann WG; Ständker L
    Biochemistry; 2005 Mar; 44(9):3644-52. PubMed ID: 15736974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of plasmin-generated bioactive fragments of IGFBP-3.
    Booth BA; Boes M; Dake BL; Bar RS
    Am J Physiol; 1999 Mar; 276(3):E450-4. PubMed ID: 10070009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A purified bovine serum albumin preparation contains an insulin-like growth factor (IGF) binding protein-3 fragment that forms ternary complexes selectively with IGF-II and the acid-labile subunit.
    Twigg SM; Hardman KV; Baxter RC
    Growth Horm IGF Res; 2000 Aug; 10(4):215-23. PubMed ID: 11032705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interactions of insulin-like growth factors (IGF) and their binding proteins with the plasminogen/plasmin activator system in cultured osteoblasts].
    Lalou C; Silve C; Segovia B; Binoux M
    Ann Endocrinol (Paris); 1994; 55(2):103-7. PubMed ID: 7802427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An N-terminal fragment of insulin-like growth factor binding protein-3 (IGFBP-3) induces apoptosis in human prostate cancer cells in an IGF-independent manner.
    Shahjee H; Bhattacharyya N; Zappala G; Wiench M; Prakash S; Rechler MM
    Growth Horm IGF Res; 2008 Jun; 18(3):188-97. PubMed ID: 17959403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.